European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 35-43 , January 2009

Descriptive epidemiology of chronic hepatitis B by using data from a hepatitis registry in Central Greece

  • Aggelos Stefos

      Affiliations

    • Department of Medicine, Academic Liver Unit, Medical School, University of Thessaly, Larissa, Greece
    • ,
  • Nikolaos Gatselis

      Affiliations

    • Department of Medicine, Academic Liver Unit, Medical School, University of Thessaly, Larissa, Greece
    • ,
  • Kalliopi Zachou

      Affiliations

    • Department of Medicine, Academic Liver Unit, Medical School, University of Thessaly, Larissa, Greece
    • Institute of Biomedical Research and Technology, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), Larissa, Greece
    • ,
  • Eirini Rigopoulou

      Affiliations

    • Department of Medicine, Academic Liver Unit, Medical School, University of Thessaly, Larissa, Greece
    • Institute of Biomedical Research and Technology, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), Larissa, Greece
    • ,
  • Christos Hadjichristodoulou

      Affiliations

    • Department of Hygiene and Epidemiology, Medical School, University of Thessaly, Larissa, Greece
    • ,
  • George N. Dalekos

      Affiliations

    • Department of Medicine, Academic Liver Unit, Medical School, University of Thessaly, Larissa, Greece
    • Institute of Biomedical Research and Technology, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), Larissa, Greece
    • Corresponding Author InformationCorresponding author. Academic Liver Unit and, Research Laboratory of Internal Medicine, Medical School, University of Thessaly, Papakiriazi 22 str, 41222 Larissa, Greece. Tel.: +30 2410 565251; fax: +30 2410 565250.

Received 22 August 2007 ,Revised 18 March 2008 ,Accepted 25 April 2008.

References 

  1. Alter MJ. EASL International Consensus Conference on Hepatitis B: epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003;39:64–69
  2. Lionis C, Frangoulis E, Koulentakis M, Biziagos E, Kouroumalis E. Prevalence of hepatitis A, B, and C markers in school children of a rural area of Crete, Greece. Eur J Epidemiol. 1997;13:417–420
  3. Koulentaki M, Spanoudakis S, Kantidaki E, et al. Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study. J Viral Hepatitis. 1999;6:243–248
  4. Zervou EK, Dalekos GN, Boumba DS, Tsianos EV. Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece. Transfusion. 2001;41:652–658
  5. Panagopoulos P, Economou A, Kasimi A, et al. Prevalence of hepatitis B and C in the maternity department of a Greek district hospital. J Matern Fetal Neonat Med. 2004;16:106–110
  6. Papaevangelou V, Hadjichristodoulou C, Cassimos D, Theodoridou M. Adherence to the screening program for HBV infection in pregnant women delivering in Greece. BMC Infect Dis. 2006;6:84
  7. Dalekos GN, Zervou E, Karabini F, Tsianos EV. Prevalence of viral markers among refugees from southern Albania: increased incidence of infection with hepatitis A, B and D viruses. Eur J Gastroenterol Hepatol. 1995;7:553–558
  8. Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50–57
  9. Toukan AU, Sharaiha ZK, Abu-el-rub OA, et al. The epidemiology of hepatitis B virus among family members in the Middle East. Am J Epideliol. 1990;132:220–232
  10. Zervou EK, Gatselis NK, Xanthi E, Ziciadis K, Georgiadou SP, Dalekos GN. Intrafamilial spread of hepatitis B virus infection in Greece. Eur J Gastroenterol Hepatol. 2005;17:911–915
  11. Gatselis N, Rigopoulou E, Stefos A, Kardasi M, Dalekos GN. Risk factors associated with HCV infection in semi-rural areas of Central Greece. Eur J Intern Med. 2007;18:48–55
  12. The EASL jury: EASL International Consensus Conference on Hepatitis B, 13–14 September 2002, Geneva, Switzerland, Consensus statement. J Hepatol. 2003;38:533–540
  13. Talwalkar JA, Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology. 2004;127:126–132
  14. Mehmet D, Meliksah E, Serif Y, Gunay S, Tuncer O, Zeynep S. Prevalence of hepatitis B infection in the southeastern region of Turkey: comparison of risk factors for HBV infection in rural and urban areas. Jpn J Infect Dis. 2005;58:15–19
  15. Silva Cde O, Azevedo Mda S, Soares CM, et al. Seroprevalence of hepatitis B virus infection in individuals with clinical evidence of hepatitis in Goiania, Goias. Detection of viral DNA and determination of subtypes. Rev Inst Med Trop Sao Paulo. 2002;44:331–334
  16. Lee DH, Kim JH, Nam JJ, Kim HR, Shin HR. Epidemiological findings of hepatitis B infection based on 1998 National Health and Nutrition Survey in Korea. J Korean Med Sci. 2002;17:457–462
  17. Dominguez A, Bruguera M, Vidal J, Plans P, Salleras L. Changes in the seroepidemiology of hepatitis B infection in Catalonia 1989–1996. Vaccine. 2000;18:2345–2350
  18. Dalekos GN, Zervou E, Merkouropoulos MH, Tsianos EV. Prevalence of hepatitis B and C viruses infection in chronic alcoholics with or without liver disease in Ioannina, Greece: low incidence of HCV infection. Eur J Epidemiol. 1996;12:21–25
  19. Erol S, Ozkurt Z, Ertek M, Tasyaran MA. Intrafamilial transmission of hepatitis B virus in the eastern Anatolian region of Turkey. Eur J Gastroenterol Hepatol. 2003;15:345–349
  20. Laskus T, Radkowski M, Lupa E, Horban A, Cianciara J, Slusarczyk J. Prevalence of markers of hepatitis viruses in out-patient alcoholics. J Hepatol. 1992;15:174–178
  21. Zignego AL, Foschi M, Laffi G, et al. «Inapparent» hepatitis B virus infection and hepatitis C virus replication in alcoholic subjects with and without liver disease. Hepatology. 1994;19:577–582
  22. Hassan MM, Hwang LY, Hatten CJ, et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology. 2002;36:1206–1213
  23. Shiomi S, Kuroki T, Minamitani S, et al. Effect of drinking on the outcome of cirrhosis in patients with hepatitis B or C. J Gastroenterol Hepatol. 1992;7:274–276
  24. Larkin J, Clayton MM, Liu J, Feitelson MA. Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice. Hepatology. 2001;34:792–797
  25. Koulentaki M, Ergazaki M, Moschandrea J, et al. Prevalence of hepatitis B and C markers in high-risk hospitalized patients in Crete: a five-year observational study. BMC Public Health. 2001;1:17
  26. Centers for Disease Control and Prevention. Hepatitis A — fact sheet, August 9, 2007. Available at http://www.cdc.gov/ncidod/diseases/hepatitis/a/afact.pdf.
  27. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases?. Am J Gastroenterol. 1995;90:201–205
  28. Arvanitidou M, Mamassi P, Vayona A. Epidemiological evidence for vaccinating wastewater treatment plant workers against hepatitis A and hepatitis B virus. Eur J Epidemiol. 2004;19:259–262
  29. Mazokopakis E, Vlachonikolis J, Philalithis A, Lionis C. Seroprevalence of hepatitis A, B and C markers in Greek warship personnel. Eur J Epidemiol. 2000;16:1069–1072
  30. Papaevangelou GJ, Gourgouli-Fotiou KP, Vissoulis HG. Epidemiologic characteristics of Hepatitis A virus infections in Greece. Am J Epidemiol. 1980;112:482–486
  31. Frosner GG, Papaevangelou G, Butler R, et al. Antibody against hepatitis A in seven European countries. I. Comparison of prevalence data in different age groups. Am J Epidemiol. 1979;110:63–69
  32. Malamitsi-Puchner A, Papacharitonos S, Sotos D, et al. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece. Eur J Epidemiol. 1996;12:297–301
  33. Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A, B and C in a well-defined area in rural Crete, Greece. J Viral Hepatitis. 1997;4:55–61
  34. Theodoropoulos G, Hadzis G. Incidence and significance of hepatitis B and A virus serologic markers in Greek cirrhotic patients. Gastroenterol Jpn. 1985;20:436–440
  35. Saab S, Lee C, Shpaner A, Ibrahim AB. Seroepidemiology of Hepatitis A in patients with chronic liver disease. J Viral Hepatitis. 2005;12:101–105
  36. Siddiqui F, Mutchnick M, Kinzie J, Peleman R, Naylor P, Ehrinpreis M. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy. Am J Gastroenterol. 2001;96:857–863

PII: S0953-6205(08)00140-4

doi: 10.1016/j.ejim.2008.04.023

European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 35-43 , January 2009

Article Tools

* Image Usage & Resolution